Novo Nordisk's new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market ...

The Tobias and Lechleiter families donated $20 million to establish the Institute for Clinical Innovation at IU Health, the largest gift in its history.

Eli Lilly and Company has received marketing authorisation from the Australian Therapeutic Goods Administration (TGA) for ...

Novo Nordisk CEO Lars Jørgensen to step down amid increasing pressure from obesity drug competition and recent share price ...

While Eli Lilly ... a new top executive will be able to address the company's challenges. "Although it might satisfy some for investors to drive a CEO transition, without meaningful change in ...

While Eli Lilly ... a new top executive will be able to address the company's challenges. "Although it might satisfy some for investors to drive a CEO transition, without meaningful change in ...